Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (471-480 of 776) with videos related to

Pageof 78
Sort By:
Neurodegenerative Disease Management|March 30, 2023
The amyloid-β pathway in Alzheimer's disease: a plain language summaryHarald Hampel, Yan Hu, John Hardy, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 4, 2014
Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCIYen Ying Lim, Robert H Pietrzak, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2023
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's DiseaseCharisse N Winston, Oliver Langford, Natalie Levin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2014
In vivo evaluation of a novel tau imaging tracer for Alzheimer's diseaseVictor L Villemagne, Shozo Furumoto, Michelle T Fodero-Tavoletti, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adultsSimone Hollands, Yen Ying Lim, Rachel Buckley, et al.
Neurobiology of Aging|April 5, 2022
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levelsAmy Woodfield, Tenielle Porter, Israa Gilani, et al.
BMC Psychiatry|October 12, 2012
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trialElizabeth V Cyarto, Nicola T Lautenschlager, Patricia M Desmond, et al.
ACS Chemical Neuroscience|September 14, 2021
Citrullination of Amyloid-β Peptides in Alzheimer's DiseaseSoumya Mukherjee, Keyla A Perez, Celine Dubois, et al.
Archives of Neurology|July 13, 2011
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer diseaseVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
Pageof 78

Showing results (471-480 of 776) with videos related to

Sort By:
Pageof 78
Neurodegenerative Disease Management|March 30, 2023
The amyloid-β pathway in Alzheimer's disease: a plain language summaryHarald Hampel, Yan Hu, John Hardy, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 4, 2014
Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCIYen Ying Lim, Robert H Pietrzak, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2023
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's DiseaseCharisse N Winston, Oliver Langford, Natalie Levin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2014
In vivo evaluation of a novel tau imaging tracer for Alzheimer's diseaseVictor L Villemagne, Shozo Furumoto, Michelle T Fodero-Tavoletti, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adultsSimone Hollands, Yen Ying Lim, Rachel Buckley, et al.
Neurobiology of Aging|April 5, 2022
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levelsAmy Woodfield, Tenielle Porter, Israa Gilani, et al.
BMC Psychiatry|October 12, 2012
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trialElizabeth V Cyarto, Nicola T Lautenschlager, Patricia M Desmond, et al.
ACS Chemical Neuroscience|September 14, 2021
Citrullination of Amyloid-β Peptides in Alzheimer's DiseaseSoumya Mukherjee, Keyla A Perez, Celine Dubois, et al.
Archives of Neurology|July 13, 2011
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer diseaseVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
Pageof 78